SciELO - Brasil - Preoperative serum levels of ca 72-4, cea, ca 19-9, and Alpha-fetoprotein in patients with gastric cancer Preoperative serum levels of ca 72-4, cea, ca 19-9, and Alpha-fetoprotein in
CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial - The Lancet Oncology
Keith Siau on Twitter: "Tumour markers #MedEd https://t.co/a0dIqRCLcb https://t.co/DJogMcTmsQ" / Twitter
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology
CA19-9 for detecting recurrence of pancreatic cancer | Scientific Reports
Elevated Preoperative Serum CA19-9 Levels in Patients with Hepatocellular Carcinoma Is Associated with Poor Prognosis after Resection
Tumor marker change and response rate in patients with elevated... | Download Table
CA 19-9 as a Marker for Gastrointestinal Cancers: A Review - M J Duffy, 1998
CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma | PLOS ONE
Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas – A retrospective tumor marker prognostic study - ScienceDirect
Comparison of two immunoassays for CA19-9, CEA and AFP tumor markers - Biochemia Medica
Premium Photo | Blood sample with abnormal ca 19 9 report or tumor marker test for pancreatic cancer
Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer
Blood sample for CA19-9 test, tumor marker for pancreatic cancer Stock Photo | Adobe Stock
Carbohydrate antigen 19-9 — tumor marker: Past, present, and future
CA 19-9 as a Serum Biomarker in Cancer | SpringerLink
Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies
Usefulness of CA 19–9 for pancreatic cancer screening in patients with new-onset diabetes - ScienceDirect
Old Dog, New Tricks: Use of CA 19-9 for Early Diagnosis of Pancreatic Cancer - Gastroenterology
CA 19.9 - Pancreatic Cancer Marker – Beacon Health Screening Centre
Table 1 from Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions. | Semantic Scholar
CA-19-9 - Diagnostic Kit
The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma | BMC Cancer | Full Text
CA 19-9 tumor marker | pancreatic cancer diagnosis | tumor marker (Everything you need to know) - YouTube
Tumor Marker CA 19-9 for Assessing Pancreatic Cancer Response - Cancer Therapy Advisor
